CRIS Current Research Information System

RAVAIOLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.650
NA - Nord America 7.071
EU - Europa 4.281
AF - Africa 549
SA - Sud America 412
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.958
VN - Vietnam 2.323
SG - Singapore 2.307
CN - Cina 2.150
IT - Italia 1.205
GB - Regno Unito 624
DE - Germania 553
HK - Hong Kong 537
SE - Svezia 430
IN - India 344
KR - Corea 317
BR - Brasile 281
NL - Olanda 257
FR - Francia 242
IE - Irlanda 184
JP - Giappone 175
RU - Federazione Russa 159
CI - Costa d'Avorio 152
ZA - Sudafrica 136
FI - Finlandia 118
SC - Seychelles 104
AT - Austria 75
BG - Bulgaria 71
ID - Indonesia 65
CH - Svizzera 64
PH - Filippine 61
CA - Canada 58
UA - Ucraina 57
TG - Togo 56
TH - Thailandia 55
PK - Pakistan 46
AR - Argentina 44
BD - Bangladesh 43
NG - Nigeria 42
ES - Italia 40
IQ - Iraq 39
PL - Polonia 36
TR - Turchia 36
EE - Estonia 34
MX - Messico 33
EC - Ecuador 31
JO - Giordania 31
TW - Taiwan 29
BE - Belgio 26
EG - Egitto 18
CL - Cile 14
HR - Croazia 13
SA - Arabia Saudita 13
GR - Grecia 12
LT - Lituania 12
PT - Portogallo 12
VE - Venezuela 12
IR - Iran 11
RO - Romania 11
AU - Australia 10
CO - Colombia 9
MY - Malesia 9
CZ - Repubblica Ceca 7
LB - Libano 7
PE - Perù 7
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CR - Costa Rica 6
KE - Kenya 6
KZ - Kazakistan 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
MA - Marocco 5
NP - Nepal 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
MK - Macedonia 4
AZ - Azerbaigian 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MT - Malta 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AO - Angola 2
GA - Gabon 2
HU - Ungheria 2
LY - Libia 2
MN - Mongolia 2
NO - Norvegia 2
UG - Uganda 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BH - Bahrain 1
Totale 20.958
Salva come PNG Salva come JPEG
Città #
Singapore 1.652
Ashburn 884
Fairfield 781
Hefei 622
Ho Chi Minh City 587
Hanoi 551
Southend 503
Hong Kong 486
San Jose 422
Chandler 415
Bologna 307
Seoul 280
Santa Clara 243
Beijing 233
Seattle 224
New York 223
Woodbridge 217
Houston 189
Dublin 183
Wilmington 183
Boardman 175
Cambridge 172
Princeton 156
Abidjan 152
Los Angeles 149
Tokyo 142
Dallas 138
Council Bluffs 133
Ann Arbor 125
Lauterbourg 109
Milan 107
Da Nang 102
Haiphong 88
Johannesburg 81
Frankfurt am Main 78
Buffalo 69
Munich 69
Sofia 69
Helsinki 66
Dong Ket 62
Bengaluru 59
Rome 58
Las Vegas 57
Lomé 56
Redondo Beach 54
Nanjing 49
Vienna 48
Turin 47
Redmond 46
São Paulo 46
Westminster 43
Berlin 41
Guangzhou 41
Bremen 39
Abeokuta 38
Shanghai 38
Bern 37
Florence 37
North Charleston 37
San Diego 36
Amsterdam 35
Brooklyn 32
Jakarta 31
Medford 31
Amman 30
Des Moines 30
Redwood City 29
Turku 29
Hải Dương 27
Biên Hòa 26
Boydton 26
Warsaw 26
Brussels 25
Dearborn 25
Falkenstein 25
Jinan 25
The Dalles 25
Can Tho 24
Hyderabad 24
Nuremberg 24
Orem 24
Bangkok 23
Bến Tre 23
London 23
Chicago 22
Phoenix 22
Tongling 22
Changsha 21
Lahore 21
Lappeenranta 21
Wuhan 21
Montreal 19
Shenzhen 19
Stockholm 19
Tianjin 19
Washington 19
Atlanta 18
Hangzhou 18
Padova 18
Quận Ba 18
Totale 13.293
Salva come PNG Salva come JPEG
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 287
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 283
Monofocal hepatocellular carcinoma: How much does size matter? 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 272
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 256
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 247
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 239
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 238
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 231
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 230
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 225
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 220
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 219
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 218
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 216
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 213
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 210
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 208
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 207
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 205
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 192
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 191
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Gut Microbiota and Celiac Disease 188
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 188
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 187
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 187
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 186
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 186
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 185
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 185
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 181
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 180
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 180
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 172
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 172
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 172
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 171
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 171
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 170
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 167
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 165
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 165
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 164
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 163
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 163
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 162
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 162
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 162
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 156
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 153
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 151
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 151
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 149
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 148
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 147
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 147
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment 145
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 145
Metformin and the Liver: Unlocking the Full Therapeutic Potential 145
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 144
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 144
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 143
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 143
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 142
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 142
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 142
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 141
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 140
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 140
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 139
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 137
Transition of patients with chronic intestinal failure from paediatric to adult center 135
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 135
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 133
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 133
Malnutrition in hospitalized patients with SARS-CoV-2 infection 132
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 132
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 132
Non-invasive tests for the prediction of primary hepatocellular carcinoma 130
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 127
Spleen stiffness by ultrasound elastography 125
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 123
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 122
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver disease 121
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 121
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 119
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 118
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 117
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 117
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection 117
Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease 117
null 115
New insights on portal hypertension's screening in people with cystic fibrosis 114
Totale 17.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 74 40 241
2021/20222.004 59 43 61 85 173 81 60 109 128 112 836 257
2022/20232.037 157 227 91 263 150 173 83 80 387 71 212 143
2023/2024958 61 134 72 75 92 241 33 65 53 66 36 30
2024/20253.616 134 421 363 243 411 166 284 150 70 352 287 735
2025/202610.041 963 1.223 955 846 784 486 1.413 460 2.191 720 0 0
Totale 21.438